Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- RILY -23.2%, HE -11.2%, SSL -2.2%, CLSK -1.5%, RNA -1.3%
Other news:
- SCPH -12.2% (FDA approval of supplemental new drug application expanding the FUROSCIX indication in heart failure; announces topline study results for SCP-111; proposed underwritten public offering of common stock and pre-funded warrants)
- FTRE -9.2% (misses by $0.10, misses on revs; guides FY24 revs below consensus)
- HUMA -8% (Announces FDA Communication of Additional Time Required to Complete Review of acellular tissue engineered vessel (ATEV) BLA for the Treatment of Vascular Trauma)
- JBLU -5.8% ($400 million convertible senior notes offering; proposes senior secured loyalty notes offering and senior secured loyalty term loan)
- SKLZ -3.6% (to delay 10-Q filing)
- GPMT -3.4% (files $500 mln mixed shelf securities offering)
- MARA -3.2% (proposes offering of $250 mln of convertible senior notes due 2031)
- MGTX -2.7% (offering of 12,500,000 of its ordinary shares at an offering price of $4.00 per share)
- LTH -2.4% (offering of 12,000,000 shares of common stock)
- SHIM -2.1% (to delay 10-Q filing)
- AMTX -1.6% (files for $234 mln mixed securities shelf offering)
- CP -1.2% (to issue TCRC lockout notice for Aug. 22)
- RIOT -1.2% (files mixed securities shelf offering; entered into $750 mln Controlled Equity Offering Sales Agreement)